期刊文献+

蜂锡合剂治疗急性放射性食管炎的最佳剂量研究 被引量:1

下载PDF
导出
摘要 目的:探讨蜂锡合剂治疗放射性食管炎的最佳有效剂量。方法:采用前瞻性、随机对照研究方法,将130例患者随机分为Ⅰ组、Ⅱ组、Ⅲ组、Ⅳ组4组,分别于500ml蜂蜜中加入1g、2g、3g、4g锡类散配成蜂锡合剂,蜂锡合剂每次口服10ml,每日4次。观察2周,每周进行1次疗效比较。结果:在可评估的121例病例中,Ⅰ组的有效率较Ⅱ组、Ⅲ组、Ⅳ组3组均低(P<0.05),但后3组间有效率差异无统计学意义(P>0.05)。结论:蜂锡合剂的疗效并不与锡类散的含量呈明显的直线关系,建议将2g∶500ml作为蜂锡合剂治疗急性放射性食管炎的最佳剂量。
出处 《中医药临床杂志》 2014年第1期23-24,共2页 Clinical Journal of Traditional Chinese Medicine
  • 相关文献

参考文献2

二级参考文献10

  • 1Coia LR,Myerson RJ,Tepper JE.Late effects of radiation therapy on the gastrointestinal tract[J].Int J Radiat Oncol Biol Phys,1995,31(5):1213-1236.
  • 2Werner-Wasik M,Pequignot E,Leeper D,et al.Predictors of severe esophagitis include use of concurrent chemotherapy,but not the length of irradiated esophagus:a multivariate analysis of patients with lung cancer treated with nonoperative therapy[J].Int J Radiat Oncol Biol Phys,2000,48(3):689-696.
  • 3Singh AK,Lockett MA,Bradley JD.Predictors of radiation-induced esophageal toxicity in patients with non-small cell lung cancer treated with three-dimensional conformal radiotherapy[J].Int J Radiat Oncol Biol Phys,2003,55(2):337-341.
  • 4Ahn SJ,Kahn D,Zhou S,et al.Dosimetric and clinical predictors for radiation-induced esophageal injury[J].Int J Radiat Oncol Biol Phvs,2005,61(2):330-347.
  • 5Maguire PD,Siblcv GS,Zhou SM,et al.Clinical and dosimetric-tors of radiation-induced esophageal toxicitv[J].Int J Radiat Oncol Biol Phys,1999,45(1):97-103.
  • 6Patel AB,Edelman MJ,Kwok Y,et al.Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery[J].Int J Radiat Oncol Biol Phys,2004,60 (4):1106-1112.
  • 7Byhardt RW,Scott C,Sause WT,et al.Response,toxicity,failure patterns,and survival in five radiation therapy oncology group (RTOG) trials of neoadjuvant and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung[J].Int J Radiat Oncol Biol Phys,1998,42(3):469-478.
  • 8Fan M,Marks LB,Hopis D,et al.Can we predict radiation-induced changes in pulmonary function tests based on the sum of predicted regional dysfunction?[J].J Clin Oncol,2001,19 (2):543-550.
  • 9Choy H,Akerley W,Safran H,et al.Multiinstitutional phase Ⅱ trial paclitaxel,carboplatin,and concurrent radiation therapy for locally advanced non-small-cell lung cancer[J].J Clin Oncol,1998,16(10):3316-3322.
  • 10Werner WM,Pequignot E,Leeper D,et al.Predictors of severe esophagitis include use of concurrent chemotherapy,but not the length of the irradiated esophagus:a multivariate analysis of patients with lung cancer treated with nonoperative therapy[J].Int J Radiat Oncol Biol Phys,2000,48(3):689-696.

共引文献5

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部